According to Golden Finance, Cesar Ruiz, chief investment officer of Swiss Pharmaceutical Group, believes that there are both traps and opportunities in 2025. Many economists are concerned that tariffs promoted by the Trump administration will cause inflation, but Ruiz is confident in market growth. He believes that in the first half of the year, the particularity of the United States will remain strong and the growth of the U.S. stock market will be enough to allow investors to record solid returns. Ruiz compared the new Treasury Secretary Becent to former Federal Reserve Chairman Ben Bernanke who served during the global financial crisis. Bernanke “is the best person to hold this position at the right time. So does Becent.” Ruiz expects that mid-sized U.S. financial companies will undergo massive integration, so now is a good time to buy stocks that may be acquired. As Trump cuts regulation, mergers and acquisitions will surge at the same time as IPOs, investment banking or trading targets will provide good opportunities. (Jin Shi)